Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00624247 · ClinicalTrials.gov registry record · Early Phase 1
Early Versus Delayed Routine HIV Testing in Connecticut Jails
A Early Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 621
- Enrollment target
NCT00624247 is a Early Phase 1 study that has completed, run by Yale University. The registered enrollment target is 621 participants.
The verdict
NCT00624247, a Early Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 621 participants
- Enrollment target
Study Summary
The objective of this non-randomized, controlled, trial is to evaluate the optimal time to approach newly incarcerated jail inmates for routine opt-out HIV testing in a manner that maximizes the number of individuals able to demonstrate capacity to consent and willingness to receive HIV testing.
Interventions
- OTHER routine HIV testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 621 participants |
| Start Date | 2007-08 |
| Est. Completion | 2008-04 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00624247
The ClinicalTrials.gov registry entry for NCT00624247 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 621 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which routine HIV testing is the first listed.
NCT00624247 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00624247 about?
NCT00624247 is a clinical study titled "Early Versus Delayed Routine HIV Testing in Connecticut Jails". The objective of this non-randomized, controlled, trial is to evaluate the optimal time to approach newly incarcerated jail inmates for routine opt-out HIV testing in a manner that maximizes the number of individuals able to demonstrate capacity to consent and willingness to receive HIV testing.
What is the current status of trial NCT00624247?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 621 participants. The study started on 2007-08. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00624247?
The interventions under investigation include: routine HIV testing (OTHER).
Who is sponsoring clinical trial NCT00624247?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.